Global Idiopathic Pulmonary Fibrosis (IPF) Market Report 2021: Market was Valued at $3271.3 Million in 2020 - Forecast to 2026
January 20, 2022 04:43 ET
|
Research and Markets
Dublin, Jan. 20, 2022 (GLOBE NEWSWIRE) -- The "Global Idiopathic Pulmonary Fibrosis (IPF) Market - Analysis By Drug Type, End User, By Region, By Country (2021 Edition): Market Insights, Pipeline...
Esbriet (Pirfenidone): An Oral Anti-fibrotic Medicine Approved for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) - Global Drug Insight and Market Forecasts, 2017-2030
December 30, 2020 08:58 ET
|
Research and Markets
Dublin, Dec. 30, 2020 (GLOBE NEWSWIRE) -- The "Esbriet (Pirfenidone) - Drug Insight and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. Esbriet (pirfenidone) -...
Global Idiopathic Pulmonary Fibrosis Treatment Market Report 2020: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2014-2025
December 10, 2020 04:33 ET
|
Research and Markets
Dublin, Dec. 10, 2020 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added...
![CPF logo without tagline](/news-release/logo/322975/0/322975.jpg?lastModified=12%2F09%2F2016%2022%3A46%3A58&size=2)
CPF Celebrates Historic Year of Progress in Pulmonary Fibrosis
December 30, 2014 14:05 ET
|
Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, Calif., Dec. 30, 2014 (GLOBE NEWSWIRE) -- The Coalition for Pulmonary Fibrosis (CPF) played an important role in much of the year's successes in Pulmonary Fibrosis (PF), helping to make...
![Barbara Barrie photo](http://www.globenewswire.com/en/Attachment/LogoDisplay/314123?filename=314123.png&size=2)
CORRECTION - Two FDA Approvals on Same Day Renew Hope for Pulmonary Fibrosis Community
October 16, 2014 17:19 ET
|
Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, CALIF., Oct. 16, 2014 (GLOBE NEWSWIRE) -- In its press release dated October 16, 2014 at 10:46 AM EST with the headline "Two FDA Approvals on Same Day Renew Hope for Pulmonary Fibrosis...
![Barbara Barrie photo](http://www.globenewswire.com/en/Attachment/LogoDisplay/314090?filename=314090.png&size=2)
Two FDA Approvals on Same Day Renew Hope for Pulmonary Fibrosis Community
October 16, 2014 10:46 ET
|
Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, CALIF., Oct. 16, 2014 (GLOBE NEWSWIRE) -- Patients, families and researchers alike have anticipated for months the U.S. Food and Drug Administration (FDA) decisions on two drugs for...
![CPF purple logo 2010](http://www.globenewswire.com/en/Attachment/LogoDisplay/313997?filename=313997.jpg&size=2)
CPF Applauds Two FDA Approvals Announced Today for First Drugs for Idiopathic Pulmonary Fibrosis
October 15, 2014 18:02 ET
|
Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, CALIF., Oct. 15, 2014 (GLOBE NEWSWIRE) -- The Coalition for Pulmonary Fibrosis (CPF) applauds the two U.S. Food and Drug Administration (FDA) approvals announced today for Idiopathic...
![CPF logo Awareness Month 2014](http://www.globenewswire.com/en/Attachment/LogoDisplay/312346?filename=312346.jpg&size=2)
Pulmonary Fibrosis Patients, Families Take Center Stage at FDA
September 29, 2014 15:25 ET
|
Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, Calif., Sept. 29, 2014 (GLOBE NEWSWIRE) -- Most FDA panels involve high-level executives and renowned medical professionals in their given areas of expertise. On Friday, however, patients...
![CPF logo without tagline](/news-release/logo/322975/0/322975.jpg?lastModified=12%2F09%2F2016%2022%3A46%3A58&size=2)
FDA Chooses Four CPF Advocates to Speak on IPF Workshop Panel
September 25, 2014 12:45 ET
|
Coalition for Pulmonary Fibrosis (CPF)
DISTRICT OF COLUMBIA, Wash., Sept. 25, 2014 (GLOBE NEWSWIRE) -- Four of the eight panelist to address the FDA tomorrow at the first U.S. Food and Drug Administration (FDA) workshop on Idiopathic...
![CPF logo without tagline](/news-release/logo/322975/0/322975.jpg?lastModified=12%2F09%2F2016%2022%3A46%3A58&size=2)
September Most Important Month in History for U.S. Patients Suffering from Idiopathic Pulmonary Fibrosis: FDA Workshop, Impending Drug Decisions, PF Month Activities
September 11, 2014 16:14 ET
|
Coalition for Pulmonary Fibrosis (CPF)
CULVER CITY, Calif., Sept. 11, 2014 (GLOBE NEWSWIRE) -- Never before have there been so many opportunities for patients to be heard regarding a deadly lung disease than this month: the U.S. Food and...